Učitavanje...
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
Recently, crosstalk between sphingolipid signaling pathways and steroid hormones has been illuminated as a possible therapeutic target. Sphingosine kinase (SK), the key enzyme metabolizing pro-apoptotic ceramide to pro-survival sphingosine-1-phosphate (S1P), is a promising therapeutic target for sol...
Spremljeno u:
| Glavni autori: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2011
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4007162/ https://ncbi.nlm.nih.gov/pubmed/21321095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JME-10-0116 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|